Navigation Links
Stonegate Report About Unigene Laboratories Inc.
Date:3/13/2008

line of potential products addresses therapeutic areas with large underserved patient populations - The Company continues to expand its pipeline with innovative peptide-based potential therapies. In addition to products for osteoporosis, Unigene's pipeline contains products that address inflammation, diabetes, cancer and other diseases. The Company has co-invented an exciting technology that could grow natural bone in targeted areas of bone fractures and weakness. Unigene has recently licensed two therapies from the University of London. One peptide-based therapy could potentially minimize damage caused by cardiac reperfusion (rapid influx of blood) in heart attack and stroke patients, and the other is a combination therapy for the treatment of inflammatory diseases.

Patented recombinant DNA manufacturing technology - Unigene's efficient recombinant DNA technology that has been validated by Big Pharma leaders including Novartis and GlaxoSmithKline, is capable of producing active pharmaceutical ingredients (APIs) in quantities that could address global markets. Although the current focus is on the osteoporosis market, this platform can be applied to hundreds of APIs in multiple large markets, including obesity, osteoarthritis, and diabetes

Recent developments - Unigene recently announced plans to broaden its activities with its joint venture partner, Shijiazhuang Pharmaceutical Group (SPG), a China-based company controlled by Lenova (LNVGY.PK) and Goldman Sachs(NYSE: GS). The intent is to upgrade SPG's technology capabilities and dramatically broaden its pipeline. This will enable the joint venture to capture a larger share of the enormous market potential for biotech products in China. UGNE's share of joint venture is 45%.

Val
'/>"/>

SOURCE Unigene Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
2. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
3. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
4. Helix BioPharma reports Q2 2008 highlights, financial results
5. Oncothyreon reports full year and fourth quarter 2007 financial results
6. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
7. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
8. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
9. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
10. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
11. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... WALTHAM, Mass., Dec. 16 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... Biotech/Janssen-Cilag,s Stelara and Abbott,s briakinumab (both interleukin inhibitors) ... in 2012 in the drug market for moderate ... will experience greater uptake, capturing nearly three times ...
(Date:12/16/2009)... -- Sequenom, Inc. (Nasdaq: SQNM ), today ... Mr. David Pendarvis to its board of directors. ... Kenneth F. Buechler, Ph.D., was president, chief scientific ... to 1994, Dr. Buechler was Biosite,s director of ... a senior research scientist for the diagnostics research ...
(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...
(Date:12/16/2009)... has been found to be effectinve in improving yelds of probiotic ... ... BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for Non-Animal ... Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... has been found to be especially effective in improving yields of ...
Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
... ( http://www.amdl.com ),AMDL, Inc. (Amex: ADL ), ... China and the US, today announced that the,Company will ... New,York City on Tuesday, October 7, 2008 at 10:30 ... Hyatt New York Hotel in the Morosco Room., ...
... Calif., Oct. 3 Isis,Pharmaceuticals, Inc. (Nasdaq: ... subsidiary, Ibis Biosciences, Inc. (Ibis), was awarded,government ... Department of,Agriculture (USDA), National Institute of Justice ... $8.4 million. These awards will fund the,utilization ...
... Phaedon Avouris of IBM and Professor Tony Heinz of ... Prize for Applied Physics on 27 September 2008 during ... of the field. The Julius Springer Prize for Applied ... innovative contribution to the field of applied physics. The ...
Other Biology Technology:AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 2Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 3Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 4Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 5Nanoscale carbon materials research wins the 2008 Julius Springer Prize for Applied Physics 2
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
(Date:12/15/2009)... The 2009 Frost & Sullivan ... presented to Sagem Securite (Safran Group) for ... award recognises the company,s expertise in advanced ... offering novel, value-added products to end users. ... ,, "Sagem Securite has been involved in ...
(Date:12/15/2009)... such as Alzheimer,s and Parkinson,s, doctors can reach into ... patient. , But they come up empty-handed when they ... ataxia disabling disorders that rob people of their ... trying to change that with the help of a ... Neurological Disorders and Stroke to establish a nationwide network ...
Breaking Biology News(10 mins):CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3William C Moyers Appointed Vice President of Foundation Relations for Hazelden 55333 1William C Moyers Appointed Vice President of Foundation Relations for Hazelden 55333 2UNTHSC Collaborates With Law Enforcement to Provide Alternatives to Dallas Prostitutes 55332 1UNTHSC Collaborates With Law Enforcement to Provide Alternatives to Dallas Prostitutes 55332 2UNTHSC Collaborates With Law Enforcement to Provide Alternatives to Dallas Prostitutes 55332 3International Travel Raises Risk of Typhoid 55331 1International Travel Raises Risk of Typhoid 55331 2
... a new study published online this week in the open ... present a high resolution genetic map for the mouse genome--one ... that for humans. , To create this map, they ... stock (HS) and the other of recombinant inbred lines (RI). ...
... scientific papers are offering a revolutionary look at the ... lost ?to bacteria. , The laboratory of Sheng Yang ... description of a plant's surface terrain and is unveiling ... take hold. The most recent paper, published in the ...
... that some simple biodegradable liquids can stop bleeding in ... impact medicine. , When the liquid, composed of protein ... peptides self-assemble into a nanoscale protective barrier gel that ... heals, the nontoxic gel is broken down into molecules ...
Other Biology News:Mapping the mouse genome 2Plants give up answers in the war on bacteria 2MIT material stops bleeding in seconds 2MIT material stops bleeding in seconds 3
... quality running into billions of dollars ... increasing pressure to reduce expensive rework ... distribution of ingredients is known to ... dissolution, stability, bio-availability and hardness. However, ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: reusable ...
... FLAG Immunoprecipitation kit allows a rapid ... an active FLAG-tagged protein. The immunoprecipitation ... which is a highly specific monoclonal ... The use of affinity resin allows ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,350-3) ... assistance. ID clarifier: rack holds ...
Biology Products: